Skip to main content
. 2020 Jun 19;13:5819–5830. doi: 10.2147/OTT.S250766

Table 1.

Distribution of TMED3 Status in Breast Cancer According to Clinicopathologic Characteristics

Characteristics Number TMED3 Expression χ2 P-value
Negative/Low High
Breast cancer 182 69 113
Matched normal 60 51 9 40.024 0.000**
Age, years
 <60 125 53 72
 ≥60 57 16 41 3.415 0.065
Tumor size
 ≤2cm 67 29 38
 >2cm 115 40 75 1.300 0.254
ER
 Negative 60 16 44
 Positive 122 53 69 4.809 0.028*
PR
 Negative 72 21 52
 Positive 110 49 61 4.625 0.032*
Her2
 Negative 129 55 74
 Positive 53 14 39 4.199 0.040*
Grade
 I 20 9 11
 II 107 35 72
 III 55 25 30 2.986 0.225
Nodal metastasis
 Negative 103 49 54
 Positive 79 20 59 9.408 0.002*
 TNM stage
 I + II 119 41 78
 III + IV 63 28 35 1.747 0.186
Triple-negative status
 Absent 147 55 92
 Present 35 14 21 0.080 0.777
 Ki67 index
 Low 75 32 43
 High 107 37 70 1.225 0.268

Notes: *P<0.05, **P<0.001

Abbreviations: ER, estrogen receptor; PR, progesterone receptor.